Date:  Wednesday, May 25, 2022, 2:30 pm ET

• Company: ResultWorks
• Presenter: Bob O’Hara, Vice President, ResultWorks

Overview:

Paragraph or two about your problem statement for the webcast.

The personalized nature of cell therapies means that organizations are required by regulators to demonstrate end-to-end visibility across the product supply chain, ensuring chain of custody, identity, and condition.

This presentation is based on a ResultWorks client, who is a T cell therapy company who had the objective of implementing a T cell tracking environment.

In this webcast, you will learn:

• The unique challenges and approaches in tracking T cells throughout their lifecycle from patient collection, to manufacturing, to treatment.
• The intrinsically distinct differences of T Cell Therapy from standard pharmaceutical biospecimen tracking and the challenges this creates in monitoring the process.